Following the value-oriented investment philosophy of Benjamin Graham, Tweedy Browne established a new position in Zoetis, the world's largest producer of medicine and vaccinations for pets and livestock. The firm's filing from August 7, 2026, revealed the acquisition of 556,060 shares valued at approximately $39.96 million. This new holding represents 3.03% of Tweedy Browne's reported portfolio.
This investment disclosure reflects trades made during the second quarter of 2026. Zoetis is a global leader in animal healthcare, developing and commercializing a wide range of products including vaccines, parasiticides, and diagnostics for both livestock and companion animals. The company, which was once a subsidiary of Pfizer, now operates independently and sells its products in over 100 countries.